Increased use of CT for pneumonia is unlikely to be the sole cause of increased hospital costs at Brigham and Women’s Hospital, according to a study presented Dec. 5 at RSNA
Increased use of CT to image pneumonia is unlikely to be the sole cause of increased hospital costs for pneumonia patients at Brigham and Women's Hospital, according to a study presented Dec. 5 at the RSNA meeting.
Michael Lu, Ph.D., a research fellow at Brigham and Women's Hospital in Boston, and colleagues retrospectively examined 1064 patients with a primary diagnosis of pneumonia from 1999 to 2006. The researchers retrieved information from hospital accounting and administration data.
The average length of stay was 9.2 days, 28.9% of patients were admitted to the ICU and 18.7% required mechanical ventilation. The researchers found the all-cause in-hospital mortality was 11.5%. Although the average number of CT studies per patient increased from 1999 to 2006, the average number of imaging studies did not. The number of chest radiographs did not change significantly with an average of 5.47 during the study period. The percentage of hospital costs remained fairly constant with an average of $20,505. Imaging costs went from $475 in 1999 to $726 in 2006.
Hospital and imaging costs have significantly increased but the fraction represented by imaging has remained constant, which suggests imaging is unlikely to be the reason for the cost increase, the researchers said.
The presenter of the abstract, Dr. Hansel Otero said it is unclear why the costs increased and this study was meant to show that increased use of CT was not the cause. A cost-effectiveness study is needed before the reason costs for the hospital jumped can be determined, he said.
The researchers compiled data from the hospital administration database and detailed information was left out, which limited the conclusions the researchers could make, he said.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.